PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25206641-6	2013	Pretreatment with puerarin (intravenous injection) attenuated the inflammatory response in rats, which was accompanied by janus-activated kinase 2 (JAK2) and signal transducers and activators of transcription 3 (STAT3) activation and nuclear factor kappa B (NF-kappaB) inhibition.	puerarin	18-26	Janus kinase 2	Rattus norvegicus	122-146	
25206641-6	2013	Pretreatment with puerarin (intravenous injection) attenuated the inflammatory response in rats, which was accompanied by janus-activated kinase 2 (JAK2) and signal transducers and activators of transcription 3 (STAT3) activation and nuclear factor kappa B (NF-kappaB) inhibition.	puerarin	18-26	Janus kinase 2	Rattus norvegicus	148-152	
19222113-0	2009	Therapeutic effect of puerarin on non-alcoholic rat fatty liver by improving leptin signal transduction through JAK2/STAT3 pathways.	puerarin	22-30	Janus kinase 2	Rattus norvegicus	112-116	
19222113-5	2009	The results showed that puerarin significantly decreased the TG, TC content in liver of the non-alcoholic fatty disease rats, ameliorated steatosis in liver, lowered liver inflammatory reaction, decreased leptin level in serum, and enhanced the expression of leptin receptor mRNA and P-JAK2/P-STAT3 level.	puerarin	24-32	Janus kinase 2	Rattus norvegicus	286-290	
19222113-6	2009	All the results demonstrated that puerarin can exhibit therapeutic effect on non-alcoholic fatty liver disease by improving leptin signal transduction through JAK2/STAT3 pathways.	puerarin	34-42	Janus kinase 2	Rattus norvegicus	159-163	
18782535-1	2008	OBJECTIVE: To observe the effects of puerarin on the expressions of leptin receptor mRNA and phosphorylated Janus kinase 2 / phosphorylated signal transducers and activators of transcription 3 (P-JAK2/P-STAT3) proteins in the liver of rats with non-alcoholic fatty liver (NAFLD).	puerarin	37-45	Janus kinase 2	Rattus norvegicus	108-122